Status:
UNKNOWN
The Efficacy of Amway Herbal Drink to Improve Skin Anti-aging
Lead Sponsor:
Amway (China) R&D Center
Conditions:
Skin Laxity
Skin Lines
Eligibility:
All Genders
30-60 years
Phase:
NA
Brief Summary
This goal of this two arms, randomized, double-blind controlled trial is to study whether Amway herbal drink could improve skin anti-aging in the middle-aged people of 30-60 years old. The main questi...
Eligibility Criteria
Inclusion
- Male and female subjects, aged 30 to 60 years, with a gender ratio of 3:7;
- Subjects are healthy;
- Visual assessment, smoothness is greater than or equal to 3 points (according to the Test Method of Efficacy Measurement of Nourishing Cosmetic Products issued by Chinese Association of Fragrance Flavor and Cosmetic Industries, the smaller the index, the better. Please refer to appendix II);
- Visual assessment, the gloss index is greater than or equal to 4 points (according to the Unilever Radiance Scale, the smaller the index is the better. Please refer to appendix III);
- Subjects could not use facial whitening and moisturizing products during the trial;
- Agree not to take other oral products with similar efficacy (such as collagen, sodium hyaluronate, etc.) during the trial. During the trial, participants agreed not to take any drugs or supplements. Do not do any medical beauty projects during the trial, do not participate in other interventional clinical research;
- Have a full understanding of the purpose, benefits, and possible risks and side effects of the study;
- Willing to comply with all research requirements and procedures;
- Understand the test procedure, read, and sign an appropriate Informed Consent Form indicating their willingness to participate.
Exclusion
- Use of any medications or supplements that may alter skin properties during the first 3 months of enrollment;
- Skin disease patients;
- Ggastrointestinal symptoms being treated;
- Lactose intolerance, allergy to fish and its products;
- Present with other organic diseases that affect intestinal function, such as history of gastrointestinal resection, colon or rectal cancer, inflammatory bowel disease, diabetes, hyperthyroidism or hypothyroidism, congenital megacolon, scleroderma, anorexia nervosa, etc.;
- Controlling diet, exercising more, or taking medications to control weight or affect appetite in the last 3 months;
- Subjects have any of the following medical history or clinical findings that may affect the evaluation of the trial effect: significant gastrointestinal disorders, liver, kidney, endocrine, hematological, respiratory and cardiovascular diseases;
- Abuse of alcohol or other illicit drugs, supplements currently or in the past, or OTC prescription drugs that may cause intestinal dysfunction or interfere with the evaluation of trial effects;
- Frequent use of drugs that may affect gastrointestinal function or the immune system, as judged by the researcher;
- Use of laxatives or other digestive substances in the 2 weeks prior to trial commencement;
- Women who are pregnant or breastfeeding, or who plan to become pregnant during the trial;
- PI considers that volunteers cannot fully cooperate with the trial arrangement.
Key Trial Info
Start Date :
August 13 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05986799
Start Date
August 13 2023
End Date
November 30 2023
Last Update
August 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ai You Mei Medical Beauty Clinic
Jinhua, Zhejiang, China